NDUFA11
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
Also known as: B14.7, NDUAB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86Y39
- Gene
- NDUFA11
- Ensembl
- ENSG00000174886
- Chromosome
- 19
- Canonical length
- 141 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria,Perinuclear theca,Principal piece,End piece
OverviewNCBI Gene
This gene encodes a subunit of the membrane-bound mitochondrial complex I. Complex I is composed of numerous subunits and functions as the NADH-ubiquinol reductase of the mitochondrial electron transport chain. Mutations in this gene are associated with severe mitochondrial complex I deficiency. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
141 residues, UniProt reviewed canonical sequence.
>Q86Y39|NDUFA11
1 MAPKVFRQYW DIPDGTDCHR KAYSTTSIAS VAGLTAAAYR VTLNPPGTFL EGVAKVGQYT
61 FTAAAVGAVF GLTTCISAHV REKPDDPLNY FLGGCAGGLT LGARTHNYGI GAAACVYFGI
121 AASLVKMGRL EGWEVFAKPK VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NDUFA11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 632 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 632 nTPM
- skeletal muscle: 406 nTPM
- adrenal gland: 396 nTPM
- liver: 345 nTPM
- tongue: 308 nTPM
- kidney: 299 nTPM
Single-cell type
- esophageal apical cells: 833 nCPM
- parietal cells: 713 nCPM
- hepatocytes: 622 nCPM
- late spermatids: 603 nCPM
- extravillous trophoblasts: 571 nCPM
- cytotrophoblasts: 521 nCPM
Immune cell
- total PBMC: 871 nTPM
- plasmacytoid DC: 552 nTPM
- classical monocyte: 529 nTPM
- T-reg: 476 nTPM
- myeloid DC: 462 nTPM
- intermediate monocyte: 442 nTPM
Brain region
- cerebellum: 172 nTPM
- white matter: 171 nTPM
- hypothalamus: 168 nTPM
- thalamus: 161 nTPM
- spinal cord: 156 nTPM
- pons: 153 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NDUFA11.
Disease | AllUniProt
Conditions NDUFA11 is implicated in, by any mechanism.
- Mitochondrial complex I deficiency, nuclear type 14 (MC1DN14) MIM:618236
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 143 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial complex I deficiency, nuclear type 14
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- -0.51
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- mitochondrial electron transport, NADH to ubiquinone
- proton motive force-driven mitochondrial ATP synthesis
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NDUFA11 as an antibody target. Whether an autoantibody or antibody against NDUFA11 could matter depends on whether native NDUFA11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NDUFA11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NDUFA11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...